A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis : Initial 3-months results of the BeSt for Kids-study

Autor: R. ten Cate, M. A. J. van Rossum, J.M. van den Berg, L.W.A. van Suijlekom-Smit, P. C. E. Hissink Muller, I. C. J. Brederije, D. M. C. Brinkman, W. P. Bekkering, Y. Koopman-Keemink, Taco W. Kuijpers, D. Schonenberg, Cornelia F Allaart

Publikováno v: Pediatric Rheumatology, 15(1). BioMed Central
Pediatric Rheumatology Online Journal
Pediatric Rheumatology
Pediatric Rheumatology, 15:11. BioMed Central Ltd.
Pediatric rheumatology online journal, 15(1). BioMed Central
Pediatric Rheumatology, 15

Combination therapy with prednisone or etanercept may induce earlier and/or more improvement in disease activity in Disease Modifying Anti Rheumatic Drug (DMARD) naive non-systemic Juvenile Idiopathic Arthritis (JIA) patients. Here we present three m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5877b335547755d27ba8be98b5ca00
https://dspace.library.uu.nl/handle/1874/349179